PMC:7299399 / 35621-35754 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T176","span":{"begin":125,"end":131},"obj":"Body_part"}],"attributes":[{"id":"A176","pred":"fma_id","subj":"T176","obj":"http://purl.org/sig/ont/fma/fma9637"}],"text":"nodeficiency virus,106−109 clinical use of PDT is limited due to hydrophobicity of PSs, poor target specificity, and limited tissue p"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T47","span":{"begin":125,"end":131},"obj":"Body_part"}],"attributes":[{"id":"A47","pred":"uberon_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"nodeficiency virus,106−109 clinical use of PDT is limited due to hydrophobicity of PSs, poor target specificity, and limited tissue p"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T326","span":{"begin":13,"end":18},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"nodeficiency virus,106−109 clinical use of PDT is limited due to hydrophobicity of PSs, poor target specificity, and limited tissue p"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T266","span":{"begin":43,"end":46},"obj":"Chemical"}],"attributes":[{"id":"A266","pred":"chebi_id","subj":"T266","obj":"http://purl.obolibrary.org/obo/CHEBI_53228"},{"id":"A267","pred":"chebi_id","subj":"T266","obj":"http://purl.obolibrary.org/obo/CHEBI_60622"}],"text":"nodeficiency virus,106−109 clinical use of PDT is limited due to hydrophobicity of PSs, poor target specificity, and limited tissue p"}

{"project":"2_test","denotations":[{"id":"32519842-12791463-158530","span":{"begin":19,"end":22},"obj":"12791463"},{"id":"32519842-22852040-158531","span":{"begin":23,"end":26},"obj":"22852040"}],"text":"nodeficiency virus,106−109 clinical use of PDT is limited due to hydrophobicity of PSs, poor target specificity, and limited tissue p"}